India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a year amid an expanding ...

Bharat Biotech International Limited (BBIL) on Tuesday announced the launch of HILLCHOL (BBV131), a novel single-strain Oral Cholera Vaccine (OCV). According to the company’s statement, HILLCHOL ...

An expert committee has advised against the adoption of malaria vaccines in India, stating the country does not meet the ...

GSK plc (NYSE:GSK) is one of the 12 best healthcare stocks to buy now. On June 12, the company announced licensing its Shigella vaccine candidate to Bharat Biotech.

The Serum Institute of India, which makes the vaccine, said the rollout includes 25 million doses, which will quadruple by the end of the year. And the cost is less than $4 a dose to keep it ...

India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a year amid an expanding ...